299 related articles for article (PubMed ID: 28390576)
61. Comparison of dimensional reduction methods for detecting and visualizing novel patterns in human and marine microbiome.
Jiang X; Hu X; Xu W; He T; Park EK
IEEE Trans Nanobioscience; 2013 Sep; 12(3):199-205. PubMed ID: 23694698
[TBL] [Abstract][Full Text] [Related]
62. Mirror, mirror on the wall: which microbiomes will help heal them all?
Nayak RR; Turnbaugh PJ
BMC Med; 2016 May; 14():72. PubMed ID: 27146150
[TBL] [Abstract][Full Text] [Related]
63. A metatranscriptomics strategy for efficient characterization of the microbiome in human tissues with low microbial biomass.
Pereira-Marques J; Ferreira RM; Figueiredo C
Gut Microbes; 2024; 16(1):2323235. PubMed ID: 38425025
[TBL] [Abstract][Full Text] [Related]
64. Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis.
Knoll RL; Forslund K; Kultima JR; Meyer CU; Kullmer U; Sunagawa S; Bork P; Gehring S
Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G327-G339. PubMed ID: 28039159
[TBL] [Abstract][Full Text] [Related]
65. Piphillin: Improved Prediction of Metagenomic Content by Direct Inference from Human Microbiomes.
Iwai S; Weinmaier T; Schmidt BL; Albertson DG; Poloso NJ; Dabbagh K; DeSantis TZ
PLoS One; 2016; 11(11):e0166104. PubMed ID: 27820856
[TBL] [Abstract][Full Text] [Related]
66. Mapping the inner workings of the microbiome: genomic- and metagenomic-based study of metabolism and metabolic interactions in the human microbiome.
Manor O; Levy R; Borenstein E
Cell Metab; 2014 Nov; 20(5):742-752. PubMed ID: 25176148
[TBL] [Abstract][Full Text] [Related]
67. Determining microbial products and identifying molecular targets in the human microbiome.
Joice R; Yasuda K; Shafquat A; Morgan XC; Huttenhower C
Cell Metab; 2014 Nov; 20(5):731-741. PubMed ID: 25440055
[TBL] [Abstract][Full Text] [Related]
68. Culturing the unculturables: strategies, challenges, and opportunities for gut microbiome study.
Yadav A; Ahlawat S; Sharma KK
J Appl Microbiol; 2023 Dec; 134(12):. PubMed ID: 38006234
[TBL] [Abstract][Full Text] [Related]
69. [Microbiotes and metagenomics].
Weissenbach J; Sghir A
Med Sci (Paris); 2016 Nov; 32(11):937-943. PubMed ID: 28008833
[TBL] [Abstract][Full Text] [Related]
70. gcMeta: a Global Catalogue of Metagenomics platform to support the archiving, standardization and analysis of microbiome data.
Shi W; Qi H; Sun Q; Fan G; Liu S; Wang J; Zhu B; Liu H; Zhao F; Wang X; Hu X; Li W; Liu J; Tian Y; Wu L; Ma J
Nucleic Acids Res; 2019 Jan; 47(D1):D637-D648. PubMed ID: 30365027
[TBL] [Abstract][Full Text] [Related]
71. Metatranscriptomics-guided genome-scale metabolic modeling of microbial communities.
Zampieri G; Campanaro S; Angione C; Treu L
Cell Rep Methods; 2023 Jan; 3(1):100383. PubMed ID: 36814842
[TBL] [Abstract][Full Text] [Related]
72. It takes guts to learn: machine learning techniques for disease detection from the gut microbiome.
Curry KD; Nute MG; Treangen TJ
Emerg Top Life Sci; 2021 Dec; 5(6):815-827. PubMed ID: 34779841
[TBL] [Abstract][Full Text] [Related]
73. Statement on analysis and interpretation of clinical human gastrointestinal microbiome testing using next-generation sequencing in South Africa.
Wojno JM; Du Toit E; Deffur A; Brink A
S Afr Med J; 2021 Mar; 111(3):203-205. PubMed ID: 33944738
[TBL] [Abstract][Full Text] [Related]
74. Public human microbiome data are dominated by highly developed countries.
Abdill RJ; Adamowicz EM; Blekhman R
PLoS Biol; 2022 Feb; 20(2):e3001536. PubMed ID: 35167588
[TBL] [Abstract][Full Text] [Related]
75. Mechanistic and Technical Challenges in Studying the Human Microbiome and Cancer Epidemiology.
Verma M
Technol Cancer Res Treat; 2017 Apr; 16(2):150-158. PubMed ID: 27121074
[TBL] [Abstract][Full Text] [Related]
76. GutBalance: a server for the human gut microbiome-based disease prediction and biomarker discovery with compositionality addressed.
Yang F; Zou Q; Gao B
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33515036
[TBL] [Abstract][Full Text] [Related]
77. Precision Metagenomics: Rapid Metagenomic Analyses for Infectious Disease Diagnostics and Public Health Surveillance.
Afshinnekoo E; Chou C; Alexander N; Ahsanuddin S; Schuetz AN; Mason CE
J Biomol Tech; 2017 Apr; 28(1):40-45. PubMed ID: 28337072
[TBL] [Abstract][Full Text] [Related]
78. Roadmap to functional characterization of the human intestinal microbiota in its interaction with the host.
Kolmeder CA; de Vos WM
J Pharm Biomed Anal; 2021 Feb; 194():113751. PubMed ID: 33328144
[TBL] [Abstract][Full Text] [Related]
79. DisBalance: a platform to automatically build balance-based disease prediction models and discover microbial biomarkers from microbiome data.
Yang F; Zou Q
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33834198
[TBL] [Abstract][Full Text] [Related]
80. Multimodal deep learning applied to classify healthy and disease states of human microbiome.
Lee SJ; Rho M
Sci Rep; 2022 Jan; 12(1):824. PubMed ID: 35039534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
